![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Total and Unbound Darunavir (DRV) Pharmacokinetics (PK) in HIV-1-Infected Pregnant Women
|
|
|
Reported by Jules Levin
Presented at the 19th Conference on Retroviruses and Opportunistic Infections (CROI), Seattle, WA, USA, March 5-8, 2012
Carmen Zorrilla,1 Rodney Wright,2 Olayemi O. Osiyemi,3 Salih Yasin,4 Bryan Baugh,5 Kimberley Brown,5 Bruce Coate, 6 Peter Verboven,7 Vera Hillewaert,7 Thomas N. Kakuda6
1University of Puerto Rico School of Medicine, San Juan, Puerto Rico; 2Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY; 3Triple O Research Institute PA, West Palm Beach, FL; 4University of Miami School of Medicine, Miami, FL; 5Janssen Services, LLC, Titusville, NJ; 6Janssen Research & Development, Titusville, NJ; 7Janssen Research & Development, Beerse, Belgium
![Pharm1.gif](../images/052613/052613-6/Pharm1.gif)
![Pharm2.gif](../images/052613/052613-6/Pharm2.gif)
![Pharm3.gif](../images/052613/052613-6/Pharm3.gif)
![Pharm4.gif](../images/052613/052613-6/Pharm4.gif)
![Pharm5.gif](../images/052613/052613-6/Pharm5.gif)
![Pharm6.gif](../images/052613/052613-6/Pharm6.gif)
![Pharm7.gif](../images/052613/052613-6/Pharm7.gif)
![Pharm8.gif](../images/052613/052613-6/Pharm8.gif)
![Pharm9.gif](../images/052613/052613-6/Pharm9.gif)
![Pharm10.gif](../images/052613/052613-6/Pharm10.gif)
![Pharm11.gif](../images/052613/052613-6/Pharm11.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|